Yesterday several consumer groups, concerned about the merger of CVS and Aetna and its harmful effects on competition and consumers, submitted comments on the merger and the proposed final judgment to the Department of Justice. In these comments, they argue that CVS's...

Almost two years ago in January 2017, the Federal Trade Commission (FTC) fined the drug company Mallinckrodt $100 million for anticompetitive practices, and required the company to allow its competitor to produce a similar medication. This settlement came after widespr...

The proposed merger of CVS and Aetna has encountered additional obstacles. Judge Richard Leon has raised concerns about whether the merger will harm consumers and scheduled a hearing for December 18th. The two companies had declared their merger complete, but the judge...

Two months ago, the Food and Drug Administration (FDA) announced a comment period on a new draft guidance intended to stop drug companies from abusing the citizen petition process to block access to new affordable generic drugs. This week, several consumer groups submi...

Lowering drug prices will be a long term project requiring action and commitments from legislators, antitrust regulators, and other officials. The Federal Trade Commission (FTC) could play an important role in several areas by opening antitrust investigations about the...